Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: studies with an intracoronary ET(A) receptor antagonist

MLA

Philip A. MacCarthy, et al. “Contrasting Inotropic Effects of Endogenous Endothelin in the Normal and Failing Human Heart: Studies with an Intracoronary ET(A) Receptor Antagonist.” Circulation, vol. 101, no. 2, Jan. 2000. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....222b3cf4af507159266272d053d4a2a5&authtype=sso&custid=ns315887.

APA

Philip A. MacCarthy, Richard M. Grocott-Mason, Ajay M. Shah, & Bernard Prendergast. (2000). Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: studies with an intracoronary ET(A) receptor antagonist. Circulation, 101(2).

Chicago

Philip A. MacCarthy, Richard M. Grocott-Mason, Ajay M. Shah, and Bernard Prendergast. 2000. “Contrasting Inotropic Effects of Endogenous Endothelin in the Normal and Failing Human Heart: Studies with an Intracoronary ET(A) Receptor Antagonist.” Circulation 101 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....222b3cf4af507159266272d053d4a2a5&authtype=sso&custid=ns315887.